Abstract

Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 3: Testing

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2012 - Volume 16, Number 4

Page(s): 322-328

Download in electronic PDF format for $75
  • Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 3: Testing Page 1
  • Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 3: Testing Page 2
  • Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 3: Testing Page 3
  • Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 3: Testing Page 4
  • Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 3: Testing Page 5
  • Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 3: Testing Page 6
  • Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 3: Testing Page 7

Abstract

A good quality-assurance program is guided by written procedures that define responsibilities and practices that ensure compounded preparations are produced with quality attributes that are appropriate to meet the needs of patients and healthcare professionals. It also contains a testing or preparation evaluation component to provide feedback on the accuracy and repeatability of the procedures used in the pharmacy. As a final check, the compounder shall review each procedure in the compounding process to verify it has been followed correctly. To ensure accuracy and completeness, the compounder shall observe the finished preparation to ensure that it appears as expected and shall investigate any discrepancies and take appropriate corrective action before the prescription is dispensed to the patient. In addition, testing may be required or recommended depending upon the situation.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2012
Pg. 146-150
Author(s): Allen Loyd V Jr
Jul/Aug 2012
Pg. 322-328
Author(s): Allen Loyd V Jr
Mar/Apr 2021
Pg. 115-124
Author(s): Kelley Brian
May/Jun 2012
Pg. 230-234
Author(s): Allen Loyd V Jr
Mar/Apr 2020
Pg. 92
Author(s): Allen Loyd V Jr
Sep/Oct 2007
Pg. 400-403
Author(s): Kupiec Thomas C
Nov/Dec 2012
Pg. 490-496
Author(s): Allen Loyd V Jr
May/Jun 2020
Pg. 180
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 491-496
Author(s): Allen Loyd V Jr
Sep/Oct 2012
Pg. 405-414
Author(s): Allen Loyd V Jr
May/Jun 2015
Pg. 215-221
Author(s): Akers Michael J
May/Jun 2014
Pg. 213-221
Mar/Apr 2015
Pg. 121-124
Author(s): Akers Michael J
Jan/Feb 2012
Pg. 64-68
Author(s): Allen Loyd V Jr
Jul/Aug 2011
Pg. 328-331
Author(s): Allen Loyd V Jr
Nov/Dec 2011
Pg. 488-496
Author(s): Allen Loyd V Jr
Sep/Oct 2011
Pg. 408-414
Author(s): Allen Loyd V Jr
Jan/Feb 2006
Pg. 36-39
Author(s): Dawson Michael F
Sep/Oct 2018
Pg. 401-404
Author(s): Martin Matt
Jul/Aug 2020
Pg. 322-326